The Critical Care Patient Monitoring Products Market is expected to grow at a CAGR of 8.6% from 2022 to 2032. FMI, in its upcoming business report, elaborates the historical and current scenario of the global Critical Care Patient Monitoring Products Market in terms of production, consumption, volume, and value. The report scrutinizes the market into various segments, regions …
Category Archives: Healthcare Trends
Favorable Government Policies to Support Coronavirus Immunoassay Market Growth to surpass US$ 6.9 Billion by 2032 at a 5.5% CAGR
The Coronavirus Immunoassay Market was worth US$ 3.7 Billion in 2021. By 2032, the market is anticipated to reach a value of approximately US$ 6.9 Billion, with sales increasing at a 5.5% CAGR throughout the assessment period. With an estimated 64.0% market share in 2021, immunoassay kits & reagents are in the lead. COVID-19 has a wide …
Heart Block Therapeutics Market to grow at a projected CAGR of 4.3% by 2032: Significant Growth and Innovation Driven by Aging Population and Medical Advancements | FMI
The heart block therapeutics market has witnessed significant growth and innovation in recent years, driven by the increasing prevalence of heart diseases and the continuous advancement in medical technology. Heart block, a condition characterized by abnormal electrical conduction in the heart, poses a substantial health risk and often requires medical intervention. As a result, the …
Systemic lupus erythematosus Drugs Market to grow USD 329.18 Billion by 2032 Growth Driven by Rising Prevalence, and Growing Availability of Novel Therapies | FMI
The global systemic lupus erythematosus (SLE) drugs market is expected to grow from USD 183.3 billion in 2020 to USD 329.18 billion by 2032, at a CAGR of 5% during the forecast period. The market growth is attributed to the rising prevalence of SLE, increasing awareness about the disease, and growing availability of novel therapies. …
Neurodegenerative Disease Market to Reach US$ 92 Billion by 2032, Driven by Demand for Holistic Therapies | FMI Insights
The pharmaceutical and healthcare industry that focuses on the diagnosis, treatment, and management of various neurodegenerative conditions is referred to as the “Neurodegenerative Disease Market.” The progressive degradation and dysfunction of the nervous system, which affects motor abilities, cognitive function, and general quality of life, are hallmarks of neurodegenerative illnesses. Alzheimer’s disease, Parkinson’s disease, Huntington’s …
Disposable Medical Sensors Market Set to Reach USD 15.31 Billion by 2032, as Wireless Health Monitoring Soars | FMI
The industry that manufactures and distributes sensors intended for single-use in medical applications is known as the “Disposable Medical Sensors Market.” Heart rate, blood pressure, temperature, oxygen levels, and other physiological factors are monitored and measured with these sensors. By delivering real-time data that aids in patient monitoring, disease diagnosis, and treatment, they serve a …
Orthotic Devices Orthotic Splints and Orthopedic Braces and Support Market is expected to witness a CAGR of 4.8% by 2032
The orthotic devices orthotic splints and orthopedic braces and support market is a growing market, with a projected CAGR of 4.8% from 2022 to 2032. This growth is being driven by a number of factors, including the aging population, the increase in the incidence of disabilities, and the growing rate of chronic and lifestyle diseases. …
Sustainable Operating Room Equipment Market is anticipated to reach US$ 52.3 Billion by 2032: The Future of Healthcare is Green | FMI
The global market for medical devices and equipment used in operating rooms or surgical suites is referred to as the “Operating Room Equipment Market.” These tools and supplies are necessary for carrying out surgical procedures and making sure patients are safe and well-cared for. Medical device producers, suppliers, and distributors are important market participants for …
Next-Gen Cancer Treatments: PD-1/PD-L1 Inhibitors Market Predicted to Hit US$123.3 Billion by 2033 | FMI Insights
In 2023, the PD-1/PD-L1 inhibitors market is expected to have a market size worth US$ 49.5 billion, and it is predicted to expand rapidly to reach US$ 123.3 billion by 2033, registering a strong CAGR of 9.6% during the forecast period. Because of the growing worldwide cancer burden, the usage of PD-1 and PD-L1 inhibitors, …
Prescription Delivery Services Market on Track to Achieve Remarkable Growth, Expected to Reach US$ 434.3 Million by 2030 with a CAGR of 17.8%
The global market for prescription delivery services is poised for robust growth, with a projected compound annual growth rate (CAGR) of 17.8% from 2022 to 2030. According to estimates, the market was valued at approximately US$ 117.2 million in 2022. Notably, pharmacy stores accounted for a substantial share of over 65% in 2021 within the …